Related Experiment Videos
Tumor suppressor p53 regulates heparanase gene expression.
1Department of Oncology, Hadassah-University Medical Center, Jerusalem, Israel.
Oncogene
|February 14, 2006
Summary
Wild-type p53 suppresses heparanase gene expression. Cancer-associated p53 mutations lead to increased heparanase, a key factor in tumor progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Heparanase enzyme degrades heparan sulfate in the extracellular matrix.
- Heparanase is implicated in tumor progression, but its gene expression regulation is unclear.
- Tumor suppressor p53 is frequently mutated in human cancers.
Purpose of the Study:
- To investigate the role of p53 in regulating heparanase gene expression.
- To determine how p53 mutations affect heparanase promoter activity.
- To elucidate the mechanisms underlying heparanase dysregulation in cancer.
Main Methods:
- Analysis of heparanase promoter activity in the presence of wild-type and mutant p53.
- Assessment of heparanase gene expression and enzymatic activity after p53 inhibition.
- Investigation of the effect of Trichostatin A on p53-mediated heparanase regulation.
Main Results:
- Wild-type p53 binds to the heparanase promoter and inhibits its activity.
- Mutant p53 variants lose inhibitory function and can activate the promoter.
- p53 inactivation increases heparanase gene expression and activity.
- Histone deacetylation is involved in heparanase promoter regulation.
Conclusions:
- Heparanase gene expression is negatively regulated by wild-type p53.
- Loss of p53 function during tumorigenesis leads to heparanase induction.
- This p53-heparanase axis offers a potential explanation for elevated heparanase in cancer.